In particular, we detected a significant increase in the levels of S100A8 in cultures of T2DM patient cells, regardless of disease group and/or cell population (i.e., in both CD14+ and CD14– populations (P < 0.001)) (Figure 3). Here, S100A8 is linked to type 2 diabetes mellitus.